These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33446526)

  • 1. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.
    Break TJ; Oikonomou V; Dutzan N; Desai JV; Swidergall M; Freiwald T; Chauss D; Harrison OJ; Alejo J; Williams DW; Pittaluga S; Lee CR; Bouladoux N; Swamydas M; Hoffman KW; Greenwell-Wild T; Bruno VM; Rosen LB; Lwin W; Renteria A; Pontejo SM; Shannon JP; Myles IA; Olbrich P; Ferré EMN; Schmitt M; Martin D; ; Barber DL; Solis NV; Notarangelo LD; Serreze DV; Matsumoto M; Hickman HD; Murphy PM; Anderson MS; Lim JK; Holland SM; Filler SG; Afzali B; Belkaid Y; Moutsopoulos NM; Lionakis MS
    Science; 2021 Jan; 371(6526):. PubMed ID: 33446526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.
    Puel A; Cypowyj S; Maródi L; Abel L; Picard C; Casanova JL
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):616-22. PubMed ID: 23026768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model.
    Bichele R; Kärner J; Truusalu K; Smidt I; Mändar R; Conti HR; Gaffen SL; Peterson P; Laan M; Kisand K
    Eur J Immunol; 2018 Mar; 48(3):464-470. PubMed ID: 29150834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.
    Uzel G; Sampaio EP; Lawrence MG; Hsu AP; Hackett M; Dorsey MJ; Noel RJ; Verbsky JW; Freeman AF; Janssen E; Bonilla FA; Pechacek J; Chandrasekaran P; Browne SK; Agharahimi A; Gharib AM; Mannurita SC; Yim JJ; Gambineri E; Torgerson T; Tran DQ; Milner JD; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1611-23. PubMed ID: 23534974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1.
    Oikonomou V; Smith G; Constantine GM; Schmitt MM; Ferré EMN; Alejo JC; Riley D; Kumar D; Dos Santos Dias L; Pechacek J; Hadjiyannis Y; Webb T; Seifert BA; Ghosh R; Walkiewicz M; Martin D; Besnard M; Snarr BD; Deljookorani S; Lee CR; DiMaggio T; Barber P; Rosen LB; Cheng A; Rastegar A; de Jesus AA; Stoddard J; Kuehn HS; Break TJ; Kong HH; Castelo-Soccio L; Colton B; Warner BM; Kleiner DE; Quezado MM; Davis JL; Fennelly KP; Olivier KN; Rosenzweig SD; Suffredini AF; Anderson MS; Swidergall M; Guillonneau C; Notarangelo LD; Goldbach-Mansky R; Neth O; Monserrat-Garcia MT; Valverde-Fernandez J; Lucena JM; Gomez-Gila AL; Garcia Rojas A; Seppänen MRJ; Lohi J; Hero M; Laakso S; Klemetti P; Lundberg V; Ekwall O; Olbrich P; Winer KK; Afzali B; Moutsopoulos NM; Holland SM; Heller T; Pittaluga S; Lionakis MS
    N Engl J Med; 2024 May; 390(20):1873-1884. PubMed ID: 38810185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased type 1 inflammation in gynecologic cervicovaginal samples in patients with APS-1.
    Hetemäki I; Saari V; Yohannes DA; Holopainen E; Holster T; Jokiranta S; Mäyränpää MI; Virtanen S; Mäkitie O; Kekäläinen E; Laakso S
    J Allergy Clin Immunol; 2024 Jun; 153(6):1736-1742. PubMed ID: 38395084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.
    Ahlgren KM; Moretti S; Lundgren BA; Karlsson I; Ahlin E; Norling A; Hallgren A; Perheentupa J; Gustafsson J; Rorsman F; Crewther PE; Rönnelid J; Bensing S; Scott HS; Kämpe O; Romani L; Lobell A
    Eur J Immunol; 2011 Jan; 41(1):235-45. PubMed ID: 21182094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.
    Hong M; Ryan KR; Arkwright PD; Gennery AR; Costigan C; Dominguez M; Denning DW; McConnell V; Cant AJ; Abinun M; Spickett GP; Swan DC; Gillespie CS; Young DA; Lilic D
    Clin Exp Immunol; 2009 Apr; 156(1):40-51. PubMed ID: 19196253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.
    van de Veerdonk FL; Plantinga TS; Hoischen A; Smeekens SP; Joosten LA; Gilissen C; Arts P; Rosentul DC; Carmichael AJ; Smits-van der Graaf CA; Kullberg BJ; van der Meer JW; Lilic D; Veltman JA; Netea MG
    N Engl J Med; 2011 Jul; 365(1):54-61. PubMed ID: 21714643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.
    Kisand K; Peterson P
    Curr Opin Pediatr; 2013 Dec; 25(6):715-21. PubMed ID: 24240291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
    Liu L; Okada S; Kong XF; Kreins AY; Cypowyj S; Abhyankar A; Toubiana J; Itan Y; Audry M; Nitschke P; Masson C; Toth B; Flatot J; Migaud M; Chrabieh M; Kochetkov T; Bolze A; Borghesi A; Toulon A; Hiller J; Eyerich S; Eyerich K; Gulácsy V; Chernyshova L; Chernyshov V; Bondarenko A; Grimaldo RM; Blancas-Galicia L; Beas IM; Roesler J; Magdorf K; Engelhard D; Thumerelle C; Burgel PR; Hoernes M; Drexel B; Seger R; Kusuma T; Jansson AF; Sawalle-Belohradsky J; Belohradsky B; Jouanguy E; Bustamante J; Bué M; Karin N; Wildbaum G; Bodemer C; Lortholary O; Fischer A; Blanche S; Al-Muhsen S; Reichenbach J; Kobayashi M; Rosales FE; Lozano CT; Kilic SS; Oleastro M; Etzioni A; Traidl-Hoffmann C; Renner ED; Abel L; Picard C; Maródi L; Boisson-Dupuis S; Puel A; Casanova JL
    J Exp Med; 2011 Aug; 208(8):1635-48. PubMed ID: 21727188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis.
    Ifrim DC; Quintin J; Meerstein-Kessel L; Plantinga TS; Joosten LA; van der Meer JW; van de Veerdonk FL; Netea MG
    Clin Exp Immunol; 2015 Sep; 181(3):434-40. PubMed ID: 25880788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.
    Hanna S; Etzioni A
    J Allergy Clin Immunol; 2011 Jun; 127(6):1433-7. PubMed ID: 21497889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans.
    Smeekens SP; Ng A; Kumar V; Johnson MD; Plantinga TS; van Diemen C; Arts P; Verwiel ET; Gresnigt MS; Fransen K; van Sommeren S; Oosting M; Cheng SC; Joosten LA; Hoischen A; Kullberg BJ; Scott WK; Perfect JR; van der Meer JW; Wijmenga C; Netea MG; Xavier RJ
    Nat Commun; 2013; 4():1342. PubMed ID: 23299892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis.
    Rösler B; Wang X; Keating ST; Joosten LAB; Netea MG; van de Veerdonk FL
    Clin Exp Immunol; 2018 Nov; 194(2):205-219. PubMed ID: 30069986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17 and infections.
    Ling Y; Puel A
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():34-40. PubMed ID: 25398490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses.
    Smeekens SP; Huttenhower C; Riza A; van de Veerdonk FL; Zeeuwen PL; Schalkwijk J; van der Meer JW; Xavier RJ; Netea MG; Gevers D
    J Innate Immun; 2014; 6(3):253-62. PubMed ID: 23796786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel
    Erdős M; Jakobicz E; Soltész B; Tóth B; Bata-Csörgő Z; Maródi L
    Front Immunol; 2020; 11():967. PubMed ID: 32547544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.
    Martinez-Martinez L; Martinez-Saavedra MT; Fuentes-Prior P; Barnadas M; Rubiales MV; Noda J; Badell I; Rodríguez-Gallego C; de la Calle-Martin O
    Mol Immunol; 2015 Dec; 68(2 Pt C):597-605. PubMed ID: 26514428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.